section name header

Y-Site Injection Compatibility (1:1 Mixture)

Vecuronium bromide

(Mfr: INR)(Conc: 1 mg/mL)

C

Remimazolam besylate

(Mfr: PAI)(Conc: 2.5 mg/mL)

Remarks:

Visually compatible for 60 min at 20.7 to 21.7°C

Ref:

4109